July 13, 2020
RESTON, Virginia – The Society of Nuclear Medicine and Molecular Imaging recognized 10 new SNMMI Fellows on Monday, July 13, during a plenary session at the society’s 2020 Annual Meeting, held virtually July 11-14. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.
All past SNMMI presidents were granted Fellowship at the 2016 Annual Meeting. Now SNMMI’s 2019-20 president, Vasken Dilsizian, MD, has joined their ranks. Also recognized were:
Xiaoyuan Chen, PhD, National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD
Paul E. Kinahan, PhD, University of Washington, Seattle
Michael A. King, PhD, University of Massachusetts Medical School, Worcester
Suzanne Lapi, PhD, University of Alabama at Birmingham
Anthony Parker, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA
Todd Peterson, PhD, Vanderbilt University Medical Center, Nashville, TN
Terrence Ruddy, MD, University of Ottawa Heart Institute, Canada
Heinrich Schelbert, MD, PhD, University of California at Los Angeles School of Medicine
Arnold Strashun, MD, State University of New York Downstate Health Sciences University; Brooklyn, NY
Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today’s medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.